• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Central Nervous System Manifestations of Long COVID: A Systematic Review

tetano

Editor, Senior Moderator
Cureus


. 2025 Apr 30;17(4):e83247.
doi: 10.7759/cureus.83247. eCollection 2025 Apr. Central Nervous System Manifestations of Long COVID: A Systematic Review

Naga Vijaya Lakshmi Divya Boorle[SUP] 1 [/SUP], Nithin C Kurra[SUP] 2 [/SUP], Nikhila Gandrakota[SUP] 3 [/SUP], Karnav Modi[SUP] 4 [/SUP], Kavya Sudireddy[SUP] 5 [/SUP], Shayan A Irfan[SUP] 6 [/SUP], Akhil Jain[SUP] 7 [/SUP], Priyanka A Parikh[SUP] 8 [/SUP], Dinesh Jillella[SUP] 9 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been one of the most widespread and devastating global pandemics, impacting hundreds of millions of people worldwide. After the cessation of active infection, the disease continues to have a disabling impact due to the persistence of fatigue, brain fog, anxiety, and depression - among the most common symptoms. This study explores the progression of neurological symptoms over 12 months and beyond following an initial diagnosis of COVID-19. Through an electronic search of eligible studies from PubMed, the Cochrane Trial Register, and Google Scholar, 10 studies were included for qualitative analysis. The systematic review highlights the similarities and differences in findings across the included studies. Olfactory dysfunction was prevalent in 0.9%-51% of individuals, and taste impairment was observed in 1.1%-21.3%. At 12 months, anxiety was more prevalent (3.5%-29%) than depression (3.5%-26%). Fatigue was the predominant neurocognitive complaint in 56% of individuals with severe COVID-19. Nearly half of individuals reported sleep difficulties. Memory impairment, followed by headaches and dizziness, also constitutes neurocognitive symptoms reported at 12 months. Our study found that there is a significant neurological burden one year following the diagnosis of COVID-19. Further studies exploring the pathological mechanisms of long-term COVID-19 are necessary to better delineate the mechanisms behind several long-term neurological manifestations of COVID-19.

Keywords: long covid; long-term; memory impairment; neurological manifestations; neuropsychiatric manifestations; olfactory dysfunction; post-covid-19 fatigue.

 
Back
Top Bottom